| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 05/27/2004 | WO2003070245B1 Mono-ester and asymmetrically substituted di-ester pro-drugs of the dopamine d1 receptor agonists |
| 05/27/2004 | WO2003064448A3 Degp protease: cleavage site identification and proteolysis of a natural target in e. coli |
| 05/27/2004 | WO2003031436A8 Heterocyclic compounds for use in the treatment of disorders of the urinary tract |
| 05/27/2004 | WO2003015705A3 In situ immunization |
| 05/27/2004 | WO2003011262A3 Use of 2-alkoxyphenyl-substituted imidazotriazinones for the treatment of diseases associated with cgmp regulated processes |
| 05/27/2004 | WO2003002109A3 Use of tyrosine kinase inhibitors for treating autoimmune diseases |
| 05/27/2004 | US20040102633 For therapy and prophylaxis of chronic obstructive pulmonary disease (COPD), asthma, airway hyper- reactivity, cough; inflammatory diseases such as inflammatory bowel disease, psoriasis, fibrositis, osteoarthritis |
| 05/27/2004 | US20040102630 For therapy of cancer, auto-immune diseases, cardiovascular diseases, infectious diseases, nephrological diseases, neurodegenerative diseases and viral infections |
| 05/27/2004 | US20040102626 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines with adenosine receptor-binding activity and their use cardiovascular preparations |
| 05/27/2004 | US20040102527 Use of cyclohexenone derivatives in the manufacture of a medicament for treating diabetic complications |
| 05/27/2004 | US20040102524 Method of treatment |
| 05/27/2004 | US20040102520 Use of (r) - ibuprofen methanesulfonamide and salts thereof in the treatment and prevention of rejection reactions of transplanted organs |
| 05/27/2004 | US20040102508 Naphathalene derivatives which bind to the ep4 receptor |
| 05/27/2004 | US20040102506 Pyrazole compositions useful as inhibitors of ERK |
| 05/27/2004 | US20040102483 Chemical compounds |
| 05/27/2004 | US20040102468 Controlling discharge of urine |
| 05/27/2004 | US20040102460 Phosphodiesterase 4 inhibitors |
| 05/27/2004 | US20040102441 Ortho-substituted anthranilic acid amides and their use as medicaments |
| 05/27/2004 | US20040102438 Gaba-receptor modulators for the treatment of neurodegenerative diseases of the eye |
| 05/27/2004 | US20040102436 Heterocyclic compound derivatives and medicines |
| 05/27/2004 | US20040102418 Compounds for the treatment of inflammatory disorders |
| 05/27/2004 | US20040102410 In particular, invention relates to alphavirus-based, preferably Sindbis virus-based, vectors and to non-alphavirus-based vectors, which have a preferential affinity for high affinity laminin receptors |
| 05/27/2004 | US20040101882 Secreted proteins |
| 05/27/2004 | US20040101579 Isoflavones and saponins in defined ratios, menopause, cancer |
| 05/27/2004 | US20040101550 Transdermal therapeutic system |
| 05/26/2004 | EP1421948A2 Use of botulinum toxins for treating sweating in humans |
| 05/26/2004 | EP1421936A1 Potassium channel opener |
| 05/26/2004 | EP1421377A2 The natural ligand for orphan g protein coupled receptor gpr86 and methods of use |
| 05/26/2004 | EP1421218A2 Model of autoimmune disease and methods for identifying agents against autoimmune disease |
| 05/26/2004 | EP1421191A2 Therapeutic binding molecules |
| 05/26/2004 | EP1421190A2 Metabolic gene polynucleotides and polypeptides and uses thereof |
| 05/26/2004 | EP1421099A1 17alfa, 21-dihydroxypregnene esters as antiandrogenic agents |
| 05/26/2004 | EP1421084A1 Polycyclic guanine phosphodiesterase v inhibitors |
| 05/26/2004 | EP1421082A1 New piperidinyl-morpholinyl derivatives as modulators of chemokine receptor activity |
| 05/26/2004 | EP1420829A2 Immunomodulatory compositions, formulations, and methods for use thereof |
| 05/26/2004 | EP1420794A1 Prostaglandin analogs as chloride channel opener |
| 05/26/2004 | EP1420783A1 Stable emulsion composition |
| 05/26/2004 | EP1420772A2 Use of beta-adrenoceptor agonists for the treatment of neurodegenerative diseases |
| 05/26/2004 | EP1420748A2 Peg-modified uricase |
| 05/26/2004 | EP1257553B1 Pyrrolopyrimidinone derivatives, process of preparation and use |
| 05/26/2004 | EP1196443B1 Erythropoietin conjugates with polyethylenglycol |
| 05/26/2004 | EP0932410B1 Mistletoe (viscum) extracts |
| 05/26/2004 | CN1500097A Human monoclonal antibodies to FC Alpha receptor (CD89) |
| 05/26/2004 | CN1500096A Osteoprotegerin in milk |
| 05/26/2004 | CN1500095A Polymer conjugates of neublastin and methods of using ssame |
| 05/26/2004 | CN1500089A Fused pyridine derivatives for use as vanilloid receptor antagonists for treating pain |
| 05/26/2004 | CN1500082A Cyano-5ubstituted dihydropyrimidine compounds and their use to treat diseases |
| 05/26/2004 | CN1499974A Remedies for vesical stimulation in association with prostatauxe |
| 05/26/2004 | CN1499971A Novel use of arylethene sulfonamide derivative |
| 05/26/2004 | CN1499969A pharmaceutical formulation contg. pyrazolo[4,3-D] pyrimidine and nitrates or thienopyrimidines and nitrates |
| 05/26/2004 | CN1499967A Kappa opiate agonists for treatment of bladder diseases |
| 05/26/2004 | CN1499927A Erythropoietin ameliorates chemotheapy-induced toxicity in vivo |
| 05/26/2004 | CN1151155C 1,5-dihydro-pyrazolo [3,4-D]-pyrimidinone derivatives |
| 05/26/2004 | CN1151133C Anthranilic acid amides and use thereof as medicaments |
| 05/26/2004 | CN1150940C Medicine for treating urinary system disease |
| 05/26/2004 | CN1150933C Chinese medicine for treating prostatitis, prostate hyperplasia and prostatauxe |
| 05/26/2004 | CN1150910C Instant bee pollen and its preparing process |
| 05/26/2004 | CN1150899C Chinese medicine-psoralen preparation used in preparing medicine |
| 05/25/2004 | US6740777 Mercaptoalkyl benzoic acid derivative are useful for inhibiting naaladase (acetylated alpha-linked acidic dipeptidase/n-/) enzyme activity |
| 05/25/2004 | US6740738 Antibodies binding to polypeptides encoded by the genes |
| 05/25/2004 | US6740681 Inhibiting angiogenesis and/or inflammation |
| 05/25/2004 | US6740666 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| 05/25/2004 | US6740657 Aminomethyl-pyrroloquinazoline compounds as thrombin receptor antagonists |
| 05/25/2004 | US6740656 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 05/25/2004 | US6740655 3',5'-cyclic nucleotide phosphodiesterase 4-specific inhibitors reduce eosinophil influx to the lungs; side effect reduction; antiinflammatory agent; antiallergens; respiratory system disorders, especially asthma |
| 05/25/2004 | US6740337 Stability |
| 05/25/2004 | CA2115170C Imidazolyl-alkenoic acids |
| 05/25/2004 | CA2101871C Transdermic pharmaceutical preparation |
| 05/21/2004 | WO2004042402A2 Diagnostics and therapeutics for diseases associated with human mas-related gene x1 (mrgx1) |
| 05/21/2004 | WO2004042077A2 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 8b (pde8b) |
| 05/21/2004 | WO2004041806A2 Substituted 4-amino-1-(pyridylmethyl) piperidine as muscarinic receptor antagonists |
| 05/21/2004 | WO2004041301A1 Antidiuretics |
| 05/21/2004 | WO2004041282A1 Receptor regulator |
| 05/21/2004 | WO2004041276A1 Remedy for overactive bladder comprising acetic acid anilide derivative as the active ingredient |
| 05/21/2004 | WO2004041266A1 Receptor function controlling agent |
| 05/21/2004 | WO2004004629A3 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists |
| 05/21/2004 | WO2004000817A3 Benzimidazole compounds and their use as estrogen agonists/antagonists |
| 05/21/2004 | WO2003088900A3 Solid forms of salts with tyrosine kinase activity |
| 05/21/2004 | WO2003055440A8 Compositions and methods for the treatement of immune related diseases |
| 05/21/2004 | WO2002090361A8 Metal substituted non centrosimmetrical phthalocyanine analogues, their preparation and use in photodynamic therapy and in vivo diagnostic |
| 05/21/2004 | CA2505322A1 Receptor function regulator |
| 05/21/2004 | CA2504805A1 Receptor regulator |
| 05/21/2004 | CA2500800A1 Substituted 4-amino-1-(pyridylmethyl) piperidine as muscarinic receptor antagonists |
| 05/20/2004 | US20040097867 Systems and methods for treating patients with processed lipoaspirate cells |
| 05/20/2004 | US20040097585 4-(2,6-difluorophenyl)-4-oxobutyric acid and derivatives; milder side effects; insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis, arteriosclerosis |
| 05/20/2004 | US20040097551 As inhibitors of glucosylceramide synthase; for therapy and prophylaxis |
| 05/20/2004 | US20040097548 For prophylaxis and therapy of from inflammation, allergic disease, pain, migraine headache, neuralgia, itching, cough, central nervous system disease, digestive organs disease, nausea, emesis, urination disorder, circulatory disease |
| 05/20/2004 | US20040097539 Hsp inductor |
| 05/20/2004 | US20040097529 Novel use of arylethene sulfonamide derivative |
| 05/20/2004 | US20040097521 Clinical treatment |
| 05/20/2004 | US20040097508 Novel heterocyclically substituted amides, their preparation and use |
| 05/20/2004 | US20040097502 For therapy and prophylaxis of disorders characterised by overexpression of transforming growth factor |
| 05/20/2004 | US20040097498 For prophylaxis and/or therapy of disorders of the urogenital system such as hypetrophy of the prostate, incontinence and in particular erectile dysfunction and female sexual dysfunction, cerebrovascular disorders |
| 05/20/2004 | US20040097495 Method for treating fibrotic diseases or other indications IIIC |
| 05/20/2004 | US20040097494 For use as nitric oxide synthase inhibitors |
| 05/20/2004 | US20040097487 To inhibits matrix metalloprotease activity |
| 05/20/2004 | US20040097465 ll-12 expression controlling agents |
| 05/20/2004 | US20040097455 Cloning of reporter genes and cDNA encoding for therapeutic proteins for the treatment of hepatic, pulmonary, renal, heart, pancreas fibrosis, keloids and hypertrophic scars, in mammals, including human beings |
| 05/20/2004 | US20040097425 Peptide compounds |
| 05/20/2004 | US20040097407 Method for the synthesis of compounds of formula I and their uses thereof |